Pharmacists’ Activities to Reduce Medication Waste: An International Survey
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Ethics
2.3. Phase One: Exploration
2.3.1. Participants’ Inclusion and Data Collection
2.3.2. Questionnaire
2.3.3. Data Analysis
2.4. Phase Two: Assessment of Implementation, Importance and Feasibility
2.4.1. Participants’ Inclusion and Data Collection
2.4.2. Questionnaire
2.4.3. Data Analysis
3. Results
3.1. The Prescribing Stage
3.2. The Dispensing Stage
3.2.1. Pharmacy Related Activities
3.2.2. Patient-Related Activities
3.3. The Leftover Stage
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix A. Questionnaire of Phase One
- 1.
- Which initiatives are taken nationally and in pharmacies to minimize medication waste?
- ▪
- Initiatives taken by prescribers.
- ▪
- Initiatives taken in the pharmacy during dispensing.
- ▪
- Initiatives taken for leftover unused medications.
- 2.
- Which phases are taken by prescribers to minimize medication waste?
- 3.
- In which cases is the number of drugs prescribed tailored on a patient’s health condition?
- 4.
- In which cases is the number of drugs prescribed tailored on costs or on other drug characteristics?
- 5.
- Which initiatives are taken in pharmacies during the dispensing of medications?
- 6.
- What is the maximum amount of days for which medications can be dispensed in your country?
- 7.
- Which initiatives are taken at the different departments of the hospital?
- 8.
- Which initiatives are taken in the hospital pharmacy while preparing/compounding the medication?
- 9.
- What is done with unused medications that are returned to the pharmacy?
Appendix B. Questionnaire of Phase Two
Activity Taken in Your Country | Important for Decreasing Medication Waste | Feasible to Implement in Practice | ||
Yes | No | 1 (Not)–5 (Very) | 1 (Not)–5 (Very) | |
The prescribing stage | ||||
Do prescribers tailor the amount of medications that they prescribe in order to limit medication waste? | ||||
Do pharmacists counsel physicians on how to combat potential medication waste? | ||||
The dispensing stage | ||||
Are pharmacists allowed to adjust the prescribed amount during dispensing in order to limit potential medication waste? | ||||
Are pharmacist allowed to remove medication from the original package in order to limit potential medication waste (e.g., split packages)? | ||||
Are pharmacists using (unit) dose dispensing systems? | ||||
Are pharmacists managing the amount of medications that is kept in stock in the pharmacy in order to limit medication waste? If yes, how?
| ||||
Are pharmacists in the hospital pharmacy scheduling patients on the same day so that medication is prepared at once in order to limit medication waste (e.g., pooling of patients with IV drugs)? | ||||
Please explain other actions taken during dispensing that limit medication waste: | ||||
Optimizing stock management by the patient | ||||
Are pharmacists enabling patients to store a part of their prescribed medications in the pharmacy? | ||||
Are pharmacists reviewing patient’s medications in order to limit medication waste (e.g., medication review, optimization of pharmacotherapy)? | ||||
Are pharmacists discussing the quantity needed for symptom improvement with the patient in order to limit medication waste (increase awareness about waste)? | ||||
Are patients allowed to bring their home medication to the hospital and use this during hospitalization? | ||||
Please explain other actions discussed during patient’s counselling that limit medication waste: | ||||
The leftover stage | ||||
Are pharmacists collecting unused medications so they can dispose of them safely? | ||||
Are pharmacists allowed to donate unused medications that are returned to the pharmacy to other countries or people in need? | ||||
Can unused medications that are returned to pharmacies by patients be re-dispensed to a different patient? ○ If yes, do the returned medications need to apply with specific criteria? Which criteria? |
Appendix C. Number of Pharmacists per Country of Origin and Work Setting that Participated in Phase One
n = 19 | Total n = 53 | Community Pharmacy n = 39 | Hospital Pharmacy n = 14 |
Australia | 2 | 2 | |
Belgium | 4 | 3 | 1 |
Canada | 2 | 2 | |
Croatia | 2 | 2 | |
Denmark | 3 | 2 | 1 |
Estonia | 5 | 4 | 1 |
Finland | 2 | 1 | 1 |
France | 2 | 1 | 1 |
Iceland | 8 | 8 | |
Ireland | 2 | 1 | 1 |
Italy | 2 | 2 | |
Malta | 2 | 1 | 1 |
Netherlands | 4 | 3 | 1 |
New Zealand | 2 | 1 | 1 |
Norway | 2 | 1 | 1 |
Spain | 2 | 2 | |
Switzerland | 3 | 2 | 1 |
United Kingdom | 2 | 2 | |
United States | 2 | 1 | 1 |
Appendix D. Number of Pharmacists per Country of Origin and Work Setting That Participated in Phase Two. 12 Pharmacists Were Working in Multiple Settings and therefore the Total Sum Exceeds 89
n = 22 | Total n = 89 | Community Pharmacy n = 13 | Hospital Pharmacy n = 66 | Academic n = 15 | Other n = 7 |
Australia | 1 | 1 | |||
Austria | 11 | 11 | 1 | ||
Belgium | 2 | 2 | |||
Canada | 2 | 2 | 1 | ||
Croatia | 1 | 1 | |||
Denmark | 1 | 1 | 1 | ||
Estonia | 2 | 2 | |||
Finland | 1 | 1 | |||
France | 6 | 6 | 2 | ||
Germany | 2 | 2 | 1 | ||
Ireland | 1 | 1 | |||
Italy | 2 | 2 | |||
Netherlands | 5 | 2 | 1 | 1 | 1 |
Norway | 24 | 21 | 2 | 1 | |
Portugal | 4 | 1 | 2 | 1 | 1 |
Romania | 2 | 2 | |||
Slovakia | 1 | 1 | |||
Slovenia | 4 | 3 | 1 |
References
- Braund, R.; Gn, G.; Matthews, R. Investigating unused medications in New Zealand. Pharm. World Sci. 2009, 31, 664–669. [Google Scholar] [CrossRef] [PubMed]
- Coma, A.; Modamio, P.; Lastra, C.F.; Bouvy, M.L.; Mariño, E.L. Returned medicines in community pharmacies of Barcelona, Spain. Pharm. World Sci. 2008, 30, 272–277. [Google Scholar] [CrossRef] [PubMed]
- Ekedahl, A.B.E. Reasons why medicines are returned to Swedish pharmacies unused. Pharm. World Sci. 2006, 28, 352–358. [Google Scholar] [CrossRef] [PubMed]
- Langley, C.; Marriott, J.; Mackridge, A.; Daniszewski, R. An analysis of returned medicines in primary care. Pharm. World Sci. 2005, 27, 296–299. [Google Scholar] [CrossRef] [PubMed]
- Law, A.V.; Sakharkar, P.; Zargarzadeh, A.; Tai, B.W.B.; Hess, K.; Hata, M.; Mireles, R.; Ha, C.; Park, T.J. Taking stock of medication wastage: Unused medications in US households. Res. Soc. Adm. Pharm. 2015, 11, 571–578. [Google Scholar] [CrossRef] [PubMed]
- Bach, P.B.; Conti, R.M.; Muller, R.J.; Schnorr, G.C.; Saltz, L.B. Overspending driven by oversized single dose vials of cancer drug. BMJ 2016, 352, i788. [Google Scholar] [CrossRef] [PubMed]
- Trueman, P.; Lowson, K.; Blighe, A.; Meszaros, A.; Wright, D.; Glanville, J. Evaluation of the Scale, Causes and Costs of Waste Medicines; YHEC/School of Pharmacy, University of London: London, UK, 2010. [Google Scholar]
- Wasserfallen, J.; Bourgeois, R.; Büla, C.; Yersin, B.; Buclin, T. Composition and Cost of Drugs Stored at Home by Elderly Patients. Ann. Pharmacother. 2003, 37, 731–737. [Google Scholar] [CrossRef] [PubMed]
- Bekker, C.L.; Melis, E.J.; Egberts, A.C.G.; Bouvy, M.L.; Gardarsdottir, H.; Van Den Bemt, B.J.F. Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy. Res. Soc. Adm. Pharm. 2018. [Google Scholar] [CrossRef] [PubMed]
- Kusturica, M.; Tomas, A.; Sabo, A. Diposal of unused drugs: Knowledge and behaviour among people around the world. Rev. Environ. Contam. Toxicol. 2017, 240, 71–104. [Google Scholar]
- Kolpin, D.; Furlong, E.; Meyer, M.; Michael Thurman, E.; Zaugg, S.; Barber, L.; Buxton, H. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36, 1202–1211. [Google Scholar] [CrossRef] [PubMed]
- Mompelat, S.; Le Bot, B.; Thomas, O. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ. Int. 2009, 35, 803–814. [Google Scholar] [CrossRef] [PubMed]
- Jobling, S.; Williams, R.; Johnson, A.; Taylor, A.; Gross-Sorokin, M.; Nolan, M.; Tyler, C.R.; Van Aerle, R.; Santos, E.; Brighty, G. Predicted exposures to steroid estrogens in U.K. rivers correlate with widespread sexual disruption in wild fish populations. Environ. Health Perspect. 2006, 114, 32–39. [Google Scholar] [CrossRef] [PubMed]
- Niemuth, N.J.; Jordan, R.; Crago, J.; Blanksma, C.; Johnson, R.; Klaper, R.D. Metformin exposure at environmentally relevant concentrations causes potential endocrine disruption in adult male fish. Environ. Toxicol. Chem. 2015, 34, 291–296. [Google Scholar] [CrossRef] [PubMed]
- FIP (International Pharmaceutical Federation). Green Pharmacy Practice: Taking Responsibility for the Environmental Impact of Medicines; International Pharmaceutical Federation: The Hague, The Netherlands, 2015. [Google Scholar]
- United Nations Development Programme. Human Development Report 2014 Sustaining Human Progress: Reducing Vulnerability and Building Resilience; United Nations Development Programme: New York, NY, USA, 2014. [Google Scholar]
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef] [Green Version]
- Boeije, H. Analysis in Qualitative Research, Think and Do; Boom Lemma Uitgevers: Den Haag, The Netherlands, 2014. (In Dutch) [Google Scholar]
- Ministry of Health Welfare and Sports. Arrangement: Preventing Waste by Limited Prescribing. Available online: https://www.rijksoverheid.nl/ministeries/ministerie-van-volksgezondheid-welzijn-en-sport/nieuws/2016/11/29/afspraak-verspilling-voorkomen-door-korter-voorschrijven (accessed on 12 December 2016).
- Maeng, D.D.; Ann, L.; Wright, E.A. Patient characteristics and healthcare utilization patterns associated with unused medications among medicare patients. Res. Soc. Adm. Pharm. 2016, 13, 1090–1094. [Google Scholar] [CrossRef] [PubMed]
- Bekker, C.L.; Van Den Bemt, B.J.F.; Egberts, A.C.G.; Bouvy, M.L.; Gardarsdottir, H. Patient and medication factors associated with preventable medication waste and possibilities for redispensing. Int. J. Clin. Pharm. 2018, 40, 704–711. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Paterson, J.M.; Anderson, G.M. “Trial” prescriptions to reduce drug wastage: Results from Canadian programs and a community demonstration project. Am. J. Manag. Care 2002, 8, 151–158. [Google Scholar] [PubMed]
- Fasola, G.; Aprile, G.; Marini, L.; Follador, A.; Mansutti, M.; Miscoria, M. Drug waste minimization as an effective strategy of cost-containment in Oncology. BMC Health Serv. Res. 2014, 14, 57. [Google Scholar] [CrossRef] [PubMed]
- Toerper, M.F.; Veltri, M.A.; Hamrock, E.; Mollenkopf, N.L.; Holt, K.; Levin, S. Medication waste reduction in pediatric pharmacy batch processes. J. Pediatr. Pharmacol. Ther. 2014, 19, 111–117. [Google Scholar] [CrossRef] [PubMed]
- Tilson, V.; Dobson, G.; Haas, C.E.; Tilson, D. Mathematical modeling to reduce waste of compounded sterile products in hospital pharmacies. Hosp. Pharm. 2014, 49, 616–627. [Google Scholar] [CrossRef] [PubMed]
- Millar, J.; McNamee, P.; Heaney, D.; Selvaraj, S.; Bond, C.; Lindsay, S.; Morton, M. Does a system of instalment dispensing for newly prescribed medicines save NHS costs? Results from a feasibility study. Fam. Pract. 2009, 26, 163–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Torjesen, I. Costs of some drugs will be displayed on packs to try to reduce waste and improve adherence. BMJ 2015, 351, h3637. [Google Scholar] [CrossRef] [PubMed]
- Jesson, J.; Business, A.; Pocock, R. Reducing medicines waste in the community. Prim. Health Care Res. Dev. 2005, 6, 117–124. [Google Scholar] [CrossRef] [Green Version]
- James, T.H.; Helms, M.L.; Braund, R. Analysis of Medications Returned to Community Pharmacies. Ann. Pharmacother. 2009, 43, 1631–1635. [Google Scholar] [CrossRef] [PubMed]
- Guirguis, K. Medications collected for disposal by outreach pharmacists in Australia. Pharm. World Sci. 2010, 32, 52–58. [Google Scholar] [CrossRef] [PubMed]
- Mackridge, A.J.; Marriott, J.F. Returned medicines: Waste or a wasted opportunity? J. Public Health 2007, 29, 258–262. [Google Scholar] [CrossRef] [PubMed]
- WHO (Would Health Organization). Guidelines for Medicine Donations, 3rd ed.; World Health Organization: Geneva, Switzerland, 2011. [Google Scholar]
- Lenzer, J. US could recycle 10 million unused prescription drugs a year, report says. BMJ 2014, 349, g7677. [Google Scholar] [CrossRef] [PubMed]
- Pomerantz, J. Recycling Expensive Medication: Why Not? Medscape Gen. Med. 2004, 6, 4. [Google Scholar]
- Bekker, C.L.; Gardarsdottir, H.; Egberts, T.C.G.; Bouvy, M.L.; van den Bemt, B.J.F. Redispensing of medicines unused by patients: A qualitative study among stakeholders. Int. J. Clin. Pharm. 2017, 39, 196–204. [Google Scholar] [CrossRef] [PubMed]
- Mcrae, D.; Allman, M.; James, D. The redistribution of medicines: Could it become a reality? Int. J. Pharm. Pract. 2016, 24, 411–418. [Google Scholar] [CrossRef] [PubMed]
Activity | Countries (n = 22) n (%) |
---|---|
The prescribing stage | |
Prescribers tailor prescription amounts | 7 (31.8) |
Counsel prescribers on efficient prescribing | 7 (31.8) |
The dispensing stage | |
Pharmacy related | |
Pharmacists adjust prescribed amounts | 10 (45.5) |
Dispense opened medication package | 11 (50.0) |
Use dose-dispensing system | 12 (54.5) |
Manage medication amounts in stock | 19 (86.4) |
Limiting storage amounts | 18 (94.7) |
Exchange medications with other pharmacies | 14 (73.7) |
Pooling patients | 7 (31.8) |
Patient related | |
Store patient’s medications | 2 (9.1) |
Review patient’s medications | 15 (68.2) |
Discuss needed quantity | 5 (22.7) |
Use home medications during hospitalization | 10 (45.5) |
The leftover stage | |
Collect unused medications | 17 (77.3) |
Donate unused medications | 4 (18.2) |
Redispense unused medications | 0 (0) |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bekker, C.L.; Gardarsdottir, H.; Egberts, A.C.G.; Bouvy, M.L.; Van den Bemt, B.J.F. Pharmacists’ Activities to Reduce Medication Waste: An International Survey. Pharmacy 2018, 6, 94. https://doi.org/10.3390/pharmacy6030094
Bekker CL, Gardarsdottir H, Egberts ACG, Bouvy ML, Van den Bemt BJF. Pharmacists’ Activities to Reduce Medication Waste: An International Survey. Pharmacy. 2018; 6(3):94. https://doi.org/10.3390/pharmacy6030094
Chicago/Turabian StyleBekker, Charlotte L., Helga Gardarsdottir, Antoine C. G. Egberts, Marcel L. Bouvy, and Bart J. F. Van den Bemt. 2018. "Pharmacists’ Activities to Reduce Medication Waste: An International Survey" Pharmacy 6, no. 3: 94. https://doi.org/10.3390/pharmacy6030094
APA StyleBekker, C. L., Gardarsdottir, H., Egberts, A. C. G., Bouvy, M. L., & Van den Bemt, B. J. F. (2018). Pharmacists’ Activities to Reduce Medication Waste: An International Survey. Pharmacy, 6(3), 94. https://doi.org/10.3390/pharmacy6030094